Associate Professor Dr. Hasniza Zaman Huri obtained her PhD and Master's in Clinical Pharmacy from the National University of Malaysia and B. Pharm (Honours) from the University of Malaya. She is the Founder and Dean of the newly established Faculty of Pharmacy, the 13th faculty at the University of Malaya, where she has worked since 1 September 2019. She is also an Associate Professor of Clinical Pharmacy and Pharmacogenomics in the Department of Clinical Pharmacy and Pharmacy Practice. Dr. Hasniza and type 2 diabetes are inseparable. Her research covers optimal management, biomarkers, insulin resistance studies, and all areas of type 2 diabetes, and her clinical pharmacy encompasses associations of drug responses and related factors, drug-related problems and pharmaceutical care issues, general biomarker studies, pharmacogenomics–pharmacodynamics studies, gene–disease–drug response associations and PK-PD studies. She has published more than 70 papers indexed in the WOS in her area of expertise. She has held various critical administrative posts—among others, the Manager of a Clinical Investigation Centre (CIC) from 2012 to 2015—and she was appointed as the Director/Head of the CIC (2015–2019). The CIC, at the University Malaya Medical Centre, is a world-class, reputable and multi-award-winning clinical trial centre.
Universiti Malaya
Kuala Lumpur, Malaysia